Phase II Study of TKI258 in Advanced Urothelial Carcinoma
Condition(s):Urothelial CancerLast Updated:December 19, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Urothelial CancerLast Updated:December 19, 2020Completed
Condition(s):Advanced Solid Tumors, Excluding Breast CancerLast Updated:December 21, 2020Completed
Condition(s):Liver NeoplasmsLast Updated:September 29, 2023Recruiting
Condition(s):Leptomeningeal MetastasisLast Updated:March 12, 2024Recruiting
Condition(s):Advanced Cancer; Lung Cancer, Nonsmall CellLast Updated:January 4, 2017Unknown status
Condition(s):Non Small Cell Lung CancerLast Updated:March 12, 2024Recruiting
Condition(s):Gastrointestinal Stromal TumorsLast Updated:March 2, 2023Recruiting
Condition(s):Leukemia; Myelogenous; Chronic; BCR-ABL (Breakpoint Cluster Region-abelson Murine Leukemia); PositiveLast Updated:March 16, 2022Unknown status
Condition(s):Chronic Myeloid LeukemiaLast Updated:August 4, 2023Active, not recruiting
Condition(s):Thyroid Cancer; Tyrosine Kinase Inhibitor; Health Related Quality of LifeLast Updated:April 21, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.